<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="In-Process" Owner="NLM">
      <PMID Version="1">35606713</PMID>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>23</Day>
      </DateRevised>
      <Article PubModel="Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1471-2458</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>22</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>May</Month>
              <Day>24</Day>
            </PubDate>
          </JournalIssue>
          <Title>BMC public health</Title>
          <ISOAbbreviation>BMC Public Health</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Community engagement on-site rapid test for chlamydia and gonorrhea among men who have sex with men: a pioneering study in Guangzhou, China.</ArticleTitle>
        <Pagination>
          <StartPage>1036</StartPage>
          <MedlinePgn>1036</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1186/s12889-022-13460-x</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) infections are prevalent among men who have sex with men (MSM) in China. However, compared to syphilis and HIV, the testing rate for chlamydia and gonorrhea remains low. The purpose of this pilot study was to evaluate the feasibility for conducting rapid nucleic acid test for chlamydia and gonorrhea in MSM community-based organizations (CBO).</AbstractText>
          <AbstractText Label="METHOD" NlmCategory="METHODS">We recruited our participants through an MSM CBO where free HV and syphilis testing were routinely provided. We collected data including social-demographic background, sexual history, chlamydia and gonorrhea testing history, and reasons for accepting this on-site rapid testing. Urine and/or anorectal swab samples were collected and tested for chlamydia and gonorrhea on-site and the testing results were delivered in about 1.5 h. Positive cases received on-site free treatment.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">From August 2020 to October 2020, 634 MSM visited the CBO for syphilis and HIV testing and 158 (158/634, 24.9%) accepted the on-site chlamydia and gonorrhea rapid test, 135 were finally enrolled. The positive rate fo chlamydia was 16.3% (22/135) and 3.0% (4/135) for gonorrhea, respectively. Only 19.3% participants had previously undergone chlamydia and gonorrhea testing and 68.9% (93/135) participants reported that they had heard of gonorrhea, 47.4% (64/135) had heard of chlamydia. The main reason for testing was "free for charge" (66.2%), followed by "convenient, 'shorter waiting time" (45.2%) and "had high-risk sexual behavior recently" (16.3%).</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This pilot study showed that the chlamydia and gonorrhea infection rate remains high among MSM, while the testing rate was low. On-site rapid testing is feasible and potentially preferred by MSM.</AbstractText>
          <CopyrightInformation>© 2022. The Author(s).</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y" EqualContrib="Y">
            <LastName>Lin</LastName>
            <ForeName>Xiao-Xin</ForeName>
            <Initials>XX</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Sexually Transmitted Diseases, Dermatology Hospital, Southern Medical University, Guangzhou, 510091, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y" EqualContrib="Y">
            <LastName>Meng</LastName>
            <ForeName>Si-Yan</ForeName>
            <Initials>SY</Initials>
            <AffiliationInfo>
              <Affiliation>UNC Project China, University of North Carolina at Chapel Hill, Guangzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ke</LastName>
            <ForeName>Wu-Jian</ForeName>
            <Initials>WJ</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Sexually Transmitted Diseases, Dermatology Hospital, Southern Medical University, Guangzhou, 510091, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhang</LastName>
            <ForeName>Xiao-Hui</ForeName>
            <Initials>XH</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Sexually Transmitted Diseases, Dermatology Hospital, Southern Medical University, Guangzhou, 510091, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Liu-Yuan</ForeName>
            <Initials>LY</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Sexually Transmitted Diseases, Dermatology Hospital, Southern Medical University, Guangzhou, 510091, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Liao</LastName>
            <ForeName>Yu-Ying</ForeName>
            <Initials>YY</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Sexually Transmitted Diseases, Dermatology Hospital, Southern Medical University, Guangzhou, 510091, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Liu</LastName>
            <ForeName>Han</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Sexually Transmitted Diseases, Dermatology Hospital, Southern Medical University, Guangzhou, 510091, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhao</LastName>
            <ForeName>Pei-Zhen</ForeName>
            <Initials>PZ</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Sexually Transmitted Diseases, Dermatology Hospital, Southern Medical University, Guangzhou, 510091, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Liang</LastName>
            <ForeName>Chun-Mei</ForeName>
            <Initials>CM</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Sexually Transmitted Diseases, Dermatology Hospital, Southern Medical University, Guangzhou, 510091, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chen</LastName>
            <ForeName>Hui-Ru</ForeName>
            <Initials>HR</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Sexually Transmitted Diseases, Dermatology Hospital, Southern Medical University, Guangzhou, 510091, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Long</LastName>
            <ForeName>Hai-Ying</ForeName>
            <Initials>HY</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Sexually Transmitted Diseases, Dermatology Hospital, Southern Medical University, Guangzhou, 510091, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yang</LastName>
            <ForeName>Bin</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Sexually Transmitted Diseases, Dermatology Hospital, Southern Medical University, Guangzhou, 510091, China. yangbin101@hotmail.com.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yang</LastName>
            <ForeName>Li-Gang</ForeName>
            <Initials>LG</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Sexually Transmitted Diseases, Dermatology Hospital, Southern Medical University, Guangzhou, 510091, China. yanglg3@hotmail.com.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>05</Month>
          <Day>24</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>BMC Public Health</MedlineTA>
        <NlmUniqueID>100968562</NlmUniqueID>
        <ISSNLinking>1471-2458</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Chlamydia</Keyword>
        <Keyword MajorTopicYN="N">Community Engagement</Keyword>
        <Keyword MajorTopicYN="N">Community-based Organization (CBO)</Keyword>
        <Keyword MajorTopicYN="N">Gonorrhea</Keyword>
        <Keyword MajorTopicYN="N">Men who have sex with men (MSM)</Keyword>
        <Keyword MajorTopicYN="N">Rapid nucleic acid testing</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>8</Month>
          <Day>15</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>18</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>23</Day>
          <Hour>23</Hour>
          <Minute>44</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>24</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>24</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35606713</ArticleId>
        <ArticleId IdType="doi">10.1186/s12889-022-13460-x</ArticleId>
        <ArticleId IdType="pii">10.1186/s12889-022-13460-x</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Chow EPF, Grulich AE, Fairley CK. Epidemiology and prevention of sexually transmitted infections in men who have sex with men at risk of HIV. Lancet HIV. 2019;6:e396–405.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S2352-3018(19)30043-8</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kent CK, Chaw JK, Wong W, et al. Prevalence of rectal, urethral, and pharyngeal chlamydia and gonorrhea detected in 2 clinical settings among men who have sex with men: San Francisco, California, 2003. Clin Infect Dis. 2005;41:67–74.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1086/430704</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yang LG, Zhang XH, Zhao PZ, et al. Gonorrhea and chlamydia prevalence in different anatomical sites among men who have sex with men: a cross-sectional study in Guangzhou. China BMC Infect Dis. 2018;18:675.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s12879-018-3579-6</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhou Y, Cai YM, Li SL, et al. Anatomical site prevalence and genotypes of Chlamydia trachomatis infections among men who have sex with men: a multi-site study in China. BMC Infect Dis. 2019;19:1041.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s12879-019-4664-1</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang X, Jia M, Chen M, et al. Prevalence and the associated risk factors of HIV, STIs and HBV among men who have sex with men in Kunming. China Int J STD AIDS. 2017;28:1115–23.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1177/0956462416688818</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>WHO. Prevention and treatment of HIV and other sexually transmitted infections among men who have sex with men and transgender people Recommendations for a public health approach, 2011. WHO; 2011.  https://www.who.int/publications/i/item/9789241501750 .</Citation>
        </Reference>
        <Reference>
          <Citation>Workowski KA, Bachmann LH, Chan PA, et al. Sexually Transmitted Infections Treatment Guidelines, 2021. MMWR Recomm Rep. 2021;70:1–187.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.15585/mmwr.rr7004a1</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wong WCW, Cheng JY, Huang XY, Choi KWY, Yang LG. Decentralising Sexually Transmitted Infection testing for MSM population in China’s primary care. Travel Med Infect Dis. 2020;37:101714.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.tmaid.2020.101714</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Refugio ON, Roberts C, West R, Klausner JD. Sexually transmissible infection control programs for men who have sex with men - what will they look like in 2020? Sex Health. 2017;14:126–32.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1071/SH16038</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lutz AR. Screening for Asymptomatic Extragenital Gonorrhea and Chlamydia in Men Who Have Sex with Men: Significance, Recommendations, and Options for Overcoming Barriers to Testing. LGBT Health. 2015;2:27–34.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1089/lgbt.2014.0056</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Haddad MS, Bifulco L, McIntosh J, Garcia MMC. Rectal specimen self-collection for chlamydia and gonorrhea screening: a cross-sectional feasibility study at a community health center. Pilot Feasibility Stud. 2021;7:208.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s40814-021-00928-7</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Meulbroek M, Ditzel E, Saz J, et al. BCN Checkpoint, a community-based centre for men who have sex with men in Barcelona, Catalonia, Spain, shows high efficiency in HIV detection and linkage to care. HIV Med. 2013;14(Suppl 3):25–8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/hiv.12054</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mayer KH, Ducharme R, Zaller ND, et al. Unprotected sex, underestimated risk, undiagnosed HIV and sexually transmitted diseases among men who have sex with men accessing testing services in a New England bathhouse. J Acquir Immune Defic Syndr. 2012;59:194–8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/QAI.0b013e31823bbecf</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ferreyra C, Redard-Jacot M, Wi T, Daily J, Kelly-Cirino C. Barriers to Access to New Gonorrhea Point-of-Care Diagnostic Tests in Low- and Middle-Income Countries and Potential Solutions: A Qualitative Interview-Based Study. Sex Transm Dis. 2020;47:698–704.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/OLQ.0000000000001238</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang TP, Liu C, Han L, et al. Community engagement in sexual health and uptake of HIV testing and syphilis testing among MSM in China: a cross-sectional online survey. J Int AIDS Soc. 2017;20:21372.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.7448/IAS.20.01/21372</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yared N, Horvath K, Fashanu O, Zhao R, Baker J, Kulasingam S. Optimizing Screening for Sexually Transmitted Infections in Men Using Self-Collected Swabs: A Systematic Review. Sex Transm Dis. 2018;45:294–300.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/OLQ.0000000000000739</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cosentino LA, Campbell T, Jett A, et al. Use of nucleic acid amplification testing for diagnosis of anorectal sexually transmitted infections. J Clin Microbiol. 2012;50:2005–8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JCM.00185-12</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gaydos CA. Review of use of a new rapid real-time PCR, the Cepheid GeneXpert(R) (Xpert) CT/NG assay, for Chlamydia trachomatis and Neisseria gonorrhoeae: results for patients while in a clinical setting. Expert Rev Mol Diagn. 2014;14:135–7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1586/14737159.2014.871495</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang R, Cui N, Long M, Mu L, Zeng H. Barriers to uptake of hepatitis C virus (HCV) health intervention among men who have sex with men in Southwest China: A qualitative study. Health Soc Care Community. 2021;29:445–52.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/hsc.13104</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
